Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Circulating tumor DNA molecular response as a complementary biomarker to RECIST in immune checkpoint inhibitor therapy: current evidence and future directions

may assist pseudoprogression interpretation, while RECIST maintains superiority in standardization, regulatory acceptance, and spatial resolution. Based on these complementary characteristics, we propose a ctDNA-enhanced RECIST framework (C) , in which ctDNA serves as an adjunct across three clinical scenarios: early e...

Jian-Shan Zheng, Lui Chi, Yong Guo · 0 citations
Review Open access Oct 2026

Pretreatment Health-Related Quality of Life and Survival in Head and Neck Cancer: A Meta-Analysis.

Pretreatment HRQoL provides multidimensional prognostic information, with Global QoL and physical, role, emotional, and social functioning showing the most consistent evidence, and these domains may help prioritize pretreatment supportive-care assessment.

Yu-Jie Hu, Qing-Fei Chu, Meng-Jia Lin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.